Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shoko Sakuraba"'
Autor:
Ryo Kinoshita, Sho Miyamoto, Shoko Sakuraba, Jun Sugihara, Motoi Suzuki, Tadaki Suzuki, Daisuke Yoneoka
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 6, Pp 1267-1270 (2024)
We assessed SARS-CoV-2 seroprevalence in Japan during July–August 2023, with a focus on 2 key age groups, 0–15 and >80 years. We estimated overall seroprevalence of 45.3% for nucleocapsid antibodies and 95.4% for spike antibodies and found notabl
Externí odkaz:
https://doaj.org/article/6d0bb47763794bddbdb8bec8897721d9
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-5 (2022)
Abstract Utilizing automatic daily body weight (BW) measurements may be helpful for assessing nutritional status and detecting underlying diseases particularly in older people who require nursing care. This preliminary study aimed to verify effective
Externí odkaz:
https://doaj.org/article/59442f42490f4e7285654e04b4aca780
Publikováno v:
Scientific reports. 12(1)
Utilizing automatic daily body weight (BW) measurements may be helpful for assessing nutritional status and detecting underlying diseases particularly in older people who require nursing care. This preliminary study aimed to verify effectiveness of e
Autor:
Naoko Shimada, Takehito Shukuya, Fumiyuki Takahashi, Kazuhisa Takahashi, Tetsuhiko Asao, Motoyasu Kato, Keiko Muraki, Rina Shibayama, Ryo Koyama, Shoko Sakuraba, Kentaro Suina, Yuichiro Honma
Publikováno v:
Cancer Treatment and Research Communications. 9:106-110
Background Chemotherapy is a standard treatment for patients with advanced non-small cell lung cancer (NSCLC); however, it occasionally causes adverse events. Serious adverse events (SAEs) are defined as any untoward medical occurrence that is relate
Publikováno v:
Journal of The Japanese Institute of Landscape Architecture. 78:619-624
Publikováno v:
Journal of The Japanese Institute of Landscape Architecture. 77:553-558
Publikováno v:
Journal of Architecture and Planning (Transactions of AIJ). 79:2241-2249
Autor:
Akiko, Murakami, Rina, Ohashi, Kunihiko, Minakata, Ryo, Koyama, Keiko, Muraki, Takehito, Shukuya, Yukiko, Namba, Ryo, Ko, Shigehiro, Yagishita, Yoko, Katsura, Fumiyuki, Takahashi, Shoko, Sakuraba, Kazuhisa, Takahashi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(9)
We retrospectively evaluated the survival benefit of dispensing erlotinib after gefitinib administration in patients with nonsmall cell lung cancer. Ninety patients treated with erlotinib in our hospital were divided into two groups: G+ group patient
Autor:
Miyoji Aiba, Shoko Sakuraba
Publikováno v:
Haigan. 34:903-910
1979年から1988年までの10年間に当院に入院した癌症例6,145例を対象に, 原発巣が横隔膜より頭側臓器にある症例 (SD群) と横隔膜より尾側臓器にある症例 (ID群) に分けて, 癌性胸膜炎・癌性腹
Autor:
Norihiro Harada, Takashi Dambara, Yasuko Yoshioka, Yoshinosuke Fukuchi, Shoko Sakuraba, Akihiko Ohwada, Naotake Satoh
Publikováno v:
Respirology (Carlton, Vic.). 7(3)
Pulmonary alveolar proteinosis (PAP) is characterized by filling of the alveoli with a periodic acid-Schiff-positive proteinaceous material. Although the pathogenesis of primary or idiopathic PAP remains unknown, it has been proposed that a deficienc